CSF
I'm Interested
Always consider the general CSF risk warning, and the offer document before investing.

Regenerative Ocean Products Australia (ROPA) is building a premium marine bioactives business at the intersection of biotechnology, personal care and environmental restoration. The company transforms two of Australia’s most damaging invasive marine species — Wakame seaweed and Longspined Sea Urchin — into high-value ingredients and finished products for global skincare and haircare markets. With government-approved biomass access, proprietary extraction methods and a dual-channel commercial strategy, ROPA is positioned to scale a capital-efficient business where revenue growth directly funds measurable marine ecosystem recovery.
Key investment drivers 1. Government-approved biomass access: Authorised harvest of invasive Undaria in Victoria, aligned with marine biosecurity objectives. 2. Ocean-positive business model: Revenue growth directly supports invasive species removal and ecosystem recovery. 3. Premium ingredient platform: Freeze-dried Undaria extract preserving antioxidants, fucoidan and polysaccharides for superior potency and formulation performance. 4. Vertical integration: Control from harvest → extraction → formulation → finished product, protecting margin and provenance. 5. Dual revenue channels: Direct-to-consumer premium skincare plus B2B marine bioactive ingredient supply. 6. Scalable biomaterials pipeline: Cosmetic-grade chitosan derived from sea urchin shells for haircare and personal care applications. 7. Capital-efficient model: Wild harvest and waste recovery pathways avoid capital-intensive farming infrastructure. 8. Aligned with global trends: Positioned within high-growth marine bioeconomy and premium clean beauty sectors.